Current Firm
Digitalis Ventures
Investments
3+ companies
Focus
Biotech, Digital Health
About Samuel Bjork
Geoffrey W. Smith trains physicians and scientists to become entrepreneurs through his Columbia University course while serving as CEO of Alcea Therapeutics, combining hands-on operating experience with his role as Managing Partner of Digitalis Ventures. He chairs the Board of Trustees at Central European University and founded the nonprofit Digitalis Commons focused on public-minded health innovation, extending his influence beyond typical venture capital into global education and civic-oriented health infrastructure.
Focus Areas
BiotechDigital HealthAIDeeptech
Investment Stage
Pre-Seed
Seed
Series A
Series B+
Notable Investments
Amit Bansal
Jonathan Friedlander
Samuel Bjork